Estradiol Valerate 40 mg/mL (Estradiol Valerate INJECTION) 40 mg/mL

Estradiol valerate binds to estrogen receptors in the body, modulating the transcription of estrogen-responsive genes. This action restores estrogenic activity in target tissues and helps regulate the pituitary secretion of gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH).

The dosage of Estradiol Valerate 40 mg/mL is determined by a healthcare provider based on the patient's medical condition, response to treatment, and other factors. It is typically administered as an intramuscular injection, with the frequency and dose tailored to individual needs.

Estradiol Valerate should not be used during pregnancy unless clearly needed. It is important to consult a healthcare provider for advice on the use of Estradiol Valerate during breastfeeding, as the safety and potential risks need to be evaluated on a case-by-case basis.

To order Estradiol Valerate 40 mg/mL from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping details, and the necessary import paperwork.

Estradiol Valerate is a long-acting estrogen therapy that is administered intramuscularly. It is similar to other estrogen therapies in its mechanism of action but may differ in dosing frequency and formulation. The choice between Estradiol Valerate and other estrogen therapies depends on individual patient needs and medical history.

Estradiol Valerate 40 mg/mL should be stored at 2-8°C, kept refrigerated, protected from light, and not frozen or shaken. Proper storage is essential to maintain the efficacy and safety of the medication.

Estradiol Valerate 40 mg/mL is administered as an intramuscular injection. The frequency and dose are determined by a healthcare provider based on the patient's medical condition and response to treatment.

The most serious risks associated with Estradiol Valerate include an increased risk of blood clots, stroke, heart attack, liver dysfunction, gallbladder disease, and certain cancers, such as breast cancer. Patients should be monitored closely for these potential risks.

Estradiol Valerate 40 mg/mL should not be used by women with a history of breast cancer, liver disease, blood clots, or heart disease. It is also contraindicated in women with undiagnosed abnormal genital bleeding or known or suspected estrogen-dependent neoplasia.